Article Type
Changed
Wed, 12/26/2018 - 15:08
Display Headline
Should a patient with a brain tumor receive anticoagulation for a thromboembolic event?
Article PDF
Author and Disclosure Information

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail adelstd@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 68(1)
Publications
Topics
Page Number
13, 16
Sections
Author and Disclosure Information

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail adelstd@ccf.org

Author and Disclosure Information

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail adelstd@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(1)
Issue
Cleveland Clinic Journal of Medicine - 68(1)
Page Number
13, 16
Page Number
13, 16
Publications
Publications
Topics
Article Type
Display Headline
Should a patient with a brain tumor receive anticoagulation for a thromboembolic event?
Display Headline
Should a patient with a brain tumor receive anticoagulation for a thromboembolic event?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media